Clinical Trial Update: SEVENFACT® for Bleeding Events in Hemophilia With Inhibitors [Phase 4]

View source ↗

Summary

Clinical trial update for SEVENFACT in Phase 4 evaluating bleeding events in patients with Hemophilia A or B with inhibitors; recruitment is ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemophilia

Drugs mentioned

• SEVENFACT (coagulation factor VIIa, recombinant)

Snippet

Sponsor: American Thrombosis and Hemostasis Network | Conditions: Hemophilia A With Inhibitor, Hemophilia B With Inhibitor | Phase 4 | Status: RECRUITING